Stockscreener 앱 받기
95.47
4.20%
3.85
전일 마감가:
$91.62
열려 있는:
$92.6
하루 거래량:
767.51K
Relative Volume:
0.71
시가총액:
$5.46B
수익:
$360.35M
순이익/손실:
$-149.57M
주가수익비율:
-32.25
EPS:
-2.96
순현금흐름:
$-81.27M
1주 성능:
+6.12%
1개월 성능:
+7.51%
6개월 성능:
-31.04%
1년 성능:
-13.53%
1일 변동 폭
$91.53
$95.55
1주일 범위
$89.00
$96.21
52주 변동 폭
$77.10
$163.71
Glaukos Corporation Stock (GKOS) Company Profile
명칭
Glaukos Corporation
전화
949-367-9600
주소
1 GLAUKOS WAY, ALISO VIEJO, CA
GKOS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GKOS
Glaukos Corporation
|
95.47 | 5.14B | 360.35M | -149.57M | -81.27M | -2.96 |
|
ABT
Abbott Laboratories
|
134.80 | 231.82B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
106.04 | 152.18B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
394.21 | 145.57B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
86.44 | 107.07B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
78.00 | 43.22B | 5.54B | 4.18B | 623.10M | 7.00 |
Glaukos Corporation Stock (GKOS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-02-19 | 업그레이드 | Mizuho | Neutral → Outperform |
| 2024-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-12-06 | 개시 | UBS | Buy |
| 2024-12-02 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-07-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-05-06 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-12-21 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-12-04 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-11-28 | 개시 | Truist | Buy |
| 2023-11-08 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-06-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-19 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-10-14 | 재개 | Stephens | Overweight |
| 2022-10-04 | 개시 | Needham | Buy |
| 2022-07-12 | 업그레이드 | Stifel | Hold → Buy |
| 2022-02-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2022-01-19 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-01-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-11-03 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-07-26 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2021-07-20 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2021-07-14 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-07-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-04-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | 업그레이드 | Citigroup | Sell → Neutral |
| 2020-12-09 | 개시 | Oppenheimer | Perform |
| 2020-11-17 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2020-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-06-15 | 개시 | Jefferies | Hold |
| 2020-03-05 | 개시 | Citigroup | Sell |
| 2020-02-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-01-06 | 업그레이드 | Berenberg | Hold → Buy |
| 2019-12-12 | 다운그레이드 | Wells Fargo | Outperform → Underperform |
| 2019-09-30 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2019-03-08 | 개시 | BTIG Research | Neutral |
| 2018-08-30 | 개시 | Berenberg | Hold |
| 2018-08-29 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-08-03 | 재확인 | Stifel | Hold |
| 2018-06-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-04-13 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-03-01 | 재확인 | Cantor Fitzgerald | Buy |
| 2017-03-02 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-01-06 | 업그레이드 | Stifel | Hold → Buy |
| 2016-10-27 | 개시 | Wells Fargo | Outperform |
모두보기
Glaukos Corporation 주식(GKOS)의 최신 뉴스
Glaukos Corp (GKOS) Trading 3.06% Higher on May 16 - GuruFocus
Tiny Tech, Big Impact: Glaukos Team Automates Vision-Saving Implants - University of San Diego
Research Analysts’ Recent Ratings Changes for Glaukos (GKOS) - Defense World
Glaukos Releases Its 2024 Sustainability Report - VisionMonday.com
Glaukos Highlights Innovation in May 2025 Presentation - TipRanks
Glaukos Announces Participation in Upcoming Investor ConferencesMay 13, 2025 - BioSpace
(GKOS) Trading Signals - news.stocktradersdaily.com
Glaukos Corporation (GKOS) Fell as its iDose Results Fell Short of Expectations - Insider Monkey
Hsbc Holdings PLC Decreases Position in Glaukos Co. (NYSE:GKOS) - Defense World
Glaukos (GKOS) Analyst Rating Update: Price Target Revised Downw - GuruFocus
What is William Blair’s Estimate for Glaukos Q1 Earnings? - Defense World
Stephens Issues Pessimistic Forecast for Glaukos (NYSE:GKOS) Stock Price - Defense World
Glaukos projects 2025 sales in the $475M-$485M range with strong iDose ramp - MSN
Glaukos (NYSE:GKOS) Stock Rating Lowered by Wells Fargo & Company - Defense World
Decoding Glaukos Corp (GKOS): A Strategic SWOT Insight - GuruFocus
Stephens cuts Glaukos stock price target to $115 from $140 By Investing.com - Investing.com South Africa
What 11 Analyst Ratings Have To Say About Glaukos - Benzinga
GKOS: Stephens & Co. Lowers Price Target for Glaukos to $115 | G - GuruFocus
Stephens cuts Glaukos stock price target to $115 from $140 - Investing.com
Glaukos Corporation (NYSE:GKOS) Q1 2025 Earnings Call Transcript - MSN
Glaukos (GKOS) Price Target Reduced by Stephens Following Earnin - GuruFocus
Glaukos (GKOS) Price Target Reduced by Stephens Following Earnings Report | GKOS Stock News - GuruFocus
Glaukos First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
GKOS Stock Falls Despite Q1 Earnings & Revenue Beat, Margins Decline - MSN
How To Trade (GKOS) - news.stocktradersdaily.com
Glaukos Corp. Reports Record Revenue and Growth - TipRanks
Glaukos (GKOS) Sees Price Target Reduction by Stifel Analyst | G - GuruFocus
Needham cuts Glaukos stock price target to $115, maintains Buy By Investing.com - Investing.com South Africa
JPMorgan cuts Glaukos stock target to $100 from $160 By Investing.com - Investing.com Nigeria
This Parsons Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday - Benzinga
Needham cuts Glaukos stock price target to $115, maintains Buy - Investing.com Australia
Glaukos (GKOS) Price Target Revised Down to $135 by Truist Securities | GKOS Stock News - GuruFocus
Needham Maintains Buy Rating for Glaukos (GKOS) with Adjusted Pr - GuruFocus
GKOS Stock Downgraded by Wells Fargo | GKOS Stock News - GuruFocus
Glaukos (GKOS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Wells downgrades Glaukos with iDose growth priced in - TipRanks
Truist Adjusts Price Target on Glaukos Corp to $135 From $140, Maintains Buy Rating - marketscreener.com
Glaukos stock hits 52-week low at $77.69 amid market challenges - Investing.com India
Glaukos (GKOS) Target Price Cut by Needham Amidst Revenue Beats - GuruFocus
Glaukos (GKOS) Target Price Cut by Needham Amidst Revenue Beats | GKOS Stock News - GuruFocus
Glaukos (GKOS) Receives Adjusted Price Target but Maintains Buy Rating | GKOS Stock News - GuruFocus
Glaukos (GKOS) Downgraded by Wells Fargo with Reduced Price Targ - GuruFocus
Glaukos Corporation (GKOS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
0.22%
자본화:
|
볼륨(24시간):